ALAN SPIVACK LIMITEDActive
Key figures
ALAN SPIVACK LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £800,000 (308% of the profit for the year).
Filed accounts2021/22–2024/25
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|
| Profit for the year | 1,199,798 | 508,369 | 221,645 | 259,919 |
| Cash at bank and in hand | 1,578,725 | 1,730,410 | 1,616,539 | 1,357,784 |
| Total assets | 3,385,562 | 2,960,697 | 3,110,999 | 2,770,377 |
| Total liabilities | 1,669,526 | 1,165,911 | — | 1,699,973 |
| Net assets / total equity | 1,761,284 | 1,821,653 | 1,623,298 | 1,083,217 |
| Average number of employees | 8 | 8 | 8 | 0 |
| Dividends paid | — | 448,000 | 420,000 | 800,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: ALAN SPIVACK LIMITED
Company
ALAN SPIVACK LIMITED is a private limited company registered with Companies House under company number 01110451. It was incorporated on 27 Apr 1973. Its status is active. The registered office is in Rickmansworth (WD3). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Profit for the year was £259,919. Net assets were £1,083,217, down 33.3% on the previous year. Cash at bank and in hand was £1,357,784. Total assets were £2,770,377 and total liabilities £1,699,973. The company had an average of 0 employees. Figures are available for 4 financial years (2021/22–2024/25).
Control and charges
One person with significant control is registered. 1 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 28 Jun 2027.